locally advanced nsclc: durvalumab and the pacific trial
Published 6 years ago • 170 plays • Length 3:22Download video MP4
Download video MP3
Similar videos
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
3:07
the use of durvalumab in locally advanced nsclc
-
2:52
examining recent pacific trial updates for durvalumab in locally advanced nsclc
-
6:00
locally advanced nsclc: approaching the pacific trial
-
5:28
durvalumab consolidation in nsclc: the pacific trial
-
1:28
durvalumab as a consolidation therapy for locally advanced nsclc
-
4:34
locally advanced nsclc: value of the pacific trial
-
4:15
safety profile of durvalumab in locally advanced nsclc
-
3:53
locally advanced nsclc: the pacific trial
-
5:13
effectively managing treatment with durvalumab
-
6:47
case 1: immunotherapy in locally advanced nsclc
-
1:45
enhancing benefit with durvalumab in nsclc after the pacific trial
-
8:36
pacific trial: durvalumab for stage 3 nsclc
-
1:38
practical considerations for durvalumab in stage 3 nsclc
-
4:19
the pacific trial: new role for immunotherapy in locally advanced nsclc (bmic-001)
-
6:06
stage iii nsclc: when to start durvalumab
-
4:03
treating locally advanced nsclc: additional concerns
-
0:58
an expert’s thoughts on the fda approval of durvalumab in locally advanced lung cancers
-
0:53
dr. schwartz on the results of the pacific trial